Nov 2018

MEDICINAL CANNABIS STILL TOO EXPENSIVE FOR MANY AUSTRALIAN PATIENTS

A new survey has found that even though the cost of medicinal cannabis has significantly decreased over the past year the pricing is still too high for many Australians. Patients are required to cover all of the cost of their treatment as no cannabis medications are subsidised by the Pharmaceutical Benefits Scheme (PBS). As a result many of them are looking for cheaper alternatives on the black market. Read the article here.

ANTG appoints new Business Operations Manager   Australian Natural Therapeutics […]

READ MORE >

ANTG’s Eve Cannabis product reveals its potential to kill or inhibit cancer cells without impacting normal cells…

READ MORE >

ANTG has listed two new THC-dominant medicinal cannabis strains on the Australian Register of Therapeutic Goods (ARTG).

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >